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Delayed-type hypersensitivity reactions are mediated  by specifically sensitized T 
cells  that  recruit  auxiliary  effector cells  via  release  of lymphokines  (1).  Classical 
tuberculin-type delayed hypersensitivity (DH)1 reactions are induced when an antigen 
is  administered  in  an  adjuvant  consisting  of a  water-in-oil  emulsion  containing 
mycobacteria  (complete Freund's  adjuvant  [CFA])  (2).  However, reactions with  a 
delayed  time-course can  also  be  elicited  in  guinea  pigs  immunized  with  protein 
antigens administered in saline or water-in-oil emulsion not containing mycobacteria. 
These reactions differ from DH by their lack of induration and their early disappear- 
ance  after  immunization  and  testing  (3).These  evanescent  delayed  reactions  that 
occur  in  animals  immunized  without  mycobacterial  adjuvants  contain  masses  of 
basophils  and  are  called  cutaneous  basophil  hypersensitivity  (CBH),  a  term  that 
allows differentiation from DH reactions that contain few basophils (4). CBH reactions 
are "carrier specific" and are mediated by sensitized T  cells (5-8), but immune serum 
can  also  mediate  cutaneous  basophil  responses  (9,  10).  These  latter  reactions  are 
hapten  specific  and  can  be  transferred  with  small  amounts  of guinea  pig  IgG1 
antibody (11). Thus, both T  and B cell-derived factors participate in the generation 
of delayed basophil-rich cutaneous hypersensitivity responses. 
The fact that T cells can mediate both DH and CBH suggests that the two reactions 
are due to separate T  cell subsets or that  a  common T  cell is responsible for both 
reactions but that  the final resulting components of the response  (such as basophil 
content) are subject to regulatory factors. This latter possibility is suggested by the 
fact that guinea pigs immunized with CFA and skin tested at 3-4 wk have classical 
DH reactions with few basophils present, but recipients of T  cells from these animals 
have delayed skin test reactions containing large basophil infiltrates (7). Thus, animals 
immunized  for  basophil-poor classical  tuberculin  reactions  have  T  cells  that  can 
mediate CBH. The CBH activity of these cells appears to be suppressed, and it has 
been proposed that transfer removes them from a suppressive influence, thus allowing 
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them to express CBH.  The nature of such a  suppressive influence is not known. The 
current  study  reports  that  when  serum  and  peritoneal  exudate  cells  (PEC)  from 
guinea pigs immunized with CFA are co-transferred intravenously to normal recipi- 
ents, the cell-mediated transfer of CBH is suppressed. The responsible serum factor is 
nonantigen  specific, has  a  molecular weight  of -70,000,  and  acts  preferentially on 
cells from donors that express basophil-poor DH. 
Materials  and  Methods 
Animals.  Hartley strain guinea pigs were obtained from Charles River Breeding Laborato- 
ries, Inc., Wilmington, MA. Female animals weighing from 250-300 g were used. 
Immunization.  Guinea pigs were immunized by footpad injection (0.1 ml X 4) using hapten- 
protein conjugate antigens (100 #g/animal) emulsified with CFA (H37 Ra; Difco Laboratories, 
Detroit, MI) with an added 3 mg/ml of ground Mycobacterium tuberculosis. The CFA emulsions 
contained either oxazolone coupled to keyhole limpet hemocyanin (Ox-KLH) or Picryl-human 
serum albumin (Pic-HSA) obtained and prepared as described previously (7,  10,  11). 
Skin Testing.  Intradermal skin testing was performed in the shaved flank by injecting soluble 
protein antigens  in  0.1  ml  phosphate-buffered  saline  (PBS;  I0  mM  potassium  phosphate- 
buffered  0.15  M  NaC1,  pH  7.4).  Macroscopic reactions were  read  at  4,  24,  and  48  h  by 
estimating the diameter and extent of erythema and induration. Animals were skin tested with 
the antigen to which the donor had  been immunized  (Ox-KLH and  PPD  or Pic-HSA and 
PPD). 
Quantitative Histology.  After 48 h, animals were killed by ether anesthesia, and flank skins 
were removed and placed in baths of freshly prepared Helly's fixative (Zenker-Formal; Fisher 
Scientific Co., Pittsburgh, PA) at room temperature. 24 h later, tissue blocks (2 mm X  10 mm) 
were excised from the center of skin reactions, washed with frequent changes of tap water, and 
stored in 70% ethanol. Subsequently, they were embedded in paraffin and 4-p.m thick sections 
were  cut  and  Giemsa  stained  at  optimum  conditions  for  identification of basophils  (10). 
Differential cell counts were made in five adjacent central 180 #m Diam oil objective (X  1,000) 
fields in the uppermost dermis (10). 
Harvesting Cells and Serum.  PEC  were obtained by the intraperitonea] injection of donors 
with 30 ml of sterile light mineral oil (Markol 52;  Exxon Corp., Linden, N  J). This was usually 
done on day 25  post-immunization, except in those experiments where cells were used early 
after immunization (day 7)  when  it was done on day 4.  3 d  later, cells were harvested with 
Hanks' buffered salt solution (HBSS), drained from the peritoneal cavity into 250 ml sterile 
siliconized centrifuged bottles, and washed three times with HBSS and then resuspended in 
RPMI media 1640 with added penicillin (100  U/ml) and streptomycin (100 #g/ml) and  10% 
fetal calf serum (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) at 4°C. 
Blood was obtained from the same animals by intracardiac needle puncture under ether 
anesthesia before cell harvesting. Serum was separated and used without storage. 
Intravenous Transfers.  Serum transfer was performed by intravenous injection using the dorsal 
foot veins. A volume of 5 ml was administered to each recipient. Cell transfer was also performed 
intravenously. This was done after serum  injection in cases where both  were administered. 
Approximately 175-200 x  106 PEC was given to each recipient, with a donor:recipient ratio of 
1  : 1. The transferred cells were at least 85% viable using the Eosin dye exclusion technique. 
Experimental Protocol (Fig. 1).  Donors were sensitized with antigens in CFA. On day 28 they 
were either skin tested or were killed for harvest of serum and PEC  for intravenous transfer. 
Normal recipients were skin tested 1-2 h later. After 48 h, macroscopic skin reactions were read, 
and animals were killed for fixation and processing of delayed skin reaction sites for quantitation 
of the cellular infiltrate. 
Affinity Chromatography. Ox-KLH (40 rag) was conjugated to 25 g of Sepharose 2B (Pharmacia 
Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N  J)  that had been activated previously 
with cyanogen bromide (12). A 32-ml column of Ox-KLH Sepharose was calibrated, and 16 ml 
of Ox-KLH plus CFA serum was applied, followed by PBS containing 0.02%  sodium azide 
(Fisher Scientific Co.). The rate of flow was 5 ml/h. The serum that passed through the column E.  BRUCE  MITCHELL AND  PHILIP  W.  ASKENASE  161 
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FIG.  1.  Experimental protocol. Donors were sensitized  with antigens in  CFA. On day 28,  they 
were either skin tested or were killed for harvest of serum and PEC for intravenous transfer.  Normal 
recipients were skin tested 1-2 h later. After 48 h, macroscopic skin reactions were read, and animals 
were killed for fixation and  processing  of delayed  reaction sites  for quantitation  of the cellular 
infiltrate. 
became diluted to 25 ml and was concentrated back to 16 ml using negative pressure. Then the 
serum was dialyzed overnight against sterile PBS and was then transferred. 
1on-Exchange Chromatography.  Serum globulins were precipitated using 18 g% sodium sulphate 
(Na2SO4).  The  precipitate  was  dissolved  with  PBS  and  dialyzed  for  3  d  against  0.01  M 
potassium phosphate buffer, pH 8.0 (starting buffer). The solution was centrifuged at  10,000 g 
for  10 min to remove debris, and the supernatant  was applied by gravity to a  10-  X  2.5-cm 
column containing diethylaminoethyl  (DEAE) cellulose 0Nhatman,  Maidstone,  Kent, U. K.) 
that  had been equilibrated previously with the starting buffer.  Fractions were collected every 
5 min at a  flow rate of 30 ml/h. IgG2 eluted with the starting buffer and then IgG1 eluted with 
a  second buffer (0.04 M  phosphate buffer, pH 6.3). The third buffer (0.5  M  NaC1) eluted the 
other proteins (11). Nominal protein concentrations in all samples were calculated on the basis 
that  each  1 mg/ml had  an  absorbance at  280  nm  of 1.3  (the extinction coefficient of IgG). 
Correction factors were used to account for dilution or concentration of the fraction pools when 
compared with the original serum. All samples were dialyzed overnight against sterile PBS and 
were then transferred. 
Gel  Filtration  Chromatography.  A  column  5.0  ×  100  cm  was  filled  with  Sephadex  G-200 
(Pharmacia Fine Chemicals, Div. of Pharmacia Inc.). After calibration,  19 ml of fresh immune 
serum was applied by gravity, followed by PBS containing 0.2% azide and  5  mM EDTA at 
4°C. The column was run over 4 d by upward flow at a pressure of 10 cm and a rate of 28 ml/ 
h, with fractions collected every 15 min. The absorbance  at  280 nm was determined  for each 
fraction and three peaks were pooled and processed as stated above and used immediately. 
Titration of Hemagglutinating Antibodies.  Coupling of oxazolone to sheep erythrocytes (SRBC) 
and  hemagglutination  was  performed  as  described  previously  (13).  Duplicate  serial  twofold 
dilutions  of each  sample  were  made  in  PBS  containing  2%  heat-inactivated  normal  rabbit 
serum, absorbed previously with Ox-SRBC (13).  Then 25/d of 0.25% vol/vol Ox-SRBC in the 
same buffer were added to each 25-/~1 dilution in conical-bottomed microtiter trays. The trays 
were incubated  for 1 h  at room temperature and then overnight at 4°C. The titer was read as 
the last well showing definite agglutination.  For anti-KLH titers, glutaraldehyde was used to 
couple KLH to SRBC (14). 
Passive Cutaneous Anaphylaxis Titration of Antibody.  Antisera (0.1  ml) in various dilutions were 
injected intradermally into 250-g normal guinea pigs. 3-4 h  later,  1 mg antigen in 1 ml of 1% 
Evans blue dye was injected intravenously. The sites were read 20 min later for the diameter of 
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Statistical Analysis.  An unpaired  t  test was used to  compute  the significance  (P <  0.05)  of 
differences between groups. 
Results 
Cell Transfer of CB~I from Guinea Pigs Immunized  for DH (Fig. 2).  PEC from donors 
immunized with Ox-KLH plus CFA 28 d previously was administered intravenously 
to recipients and transferred the ability to elicit delayed responses to the immunizing 
antigen Ox-KLH (Fig. 2 a). Macroscopically, the reaction size in the recipients was 
significantly smaller  (P  <  0.001)  than  those  elicited  in  the  donors.  As  reported 
previously (7), skin reactions elicited with Ox-KLH in the recipients were basophil 
rich (Fig. 2 a), unlike the DH responses of the donors that were basophil poor (P < 
0.001). Fig. 2 b shows that PPD skin testing yielded results comparable to those seen 
with the immunizing hapten protein conjugate. The reactions elicited in cell transfer 
recipients  were  smaller  than  those  of the  actively  immunized  (P  <  0.001)  and 
contained significantly increased  numbers  of basophils  (P <  0.001).  These  results 
suggest that  (a)  cells are  able to transfer delayed responses  but  are  insufficient to 
induce DH and instead induce reactions resembling CBH, and (b) actively immunized 
animals seem to possess the ability to inhibit cell-mediated CBH. 
Immune Serum Modulates Macroscopic and Microscopic Aspects of Delayed Skin Test Responses 
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Fro.  2.  Macroscopic erythema and microscopic bsaophils in skin test responses of actively sensitized 
guinea pigs or recipients of immune PEC. Donors were immunized with 100 p,g Ox-KLH emulsified 
with CFA, PEC were harvested at 28 d. Data were pooled from six experiments. Actively immunized 
and PEC recipient animals were skin tested with  100 #g Ox-KLH (Fig.  2 a)  and with 25 p,g PPD 
(Fig. 2 b). rn, erythema; ~, basophils. E.  BRUCE  MITCHELL  AND  PHILIP  W.  ASKENASE  163 
in Recipients of Immune Cells  (Fig.  3 and Table I).  When  immune PEC  and immune 
serum that  were harvested  28  d  after immunization were transferred  intravenously, 
skin testing with the immunizing conjugate Ox-KLH  elicited  delayed reactions that 
were macroscopically larger than those seen in animals that received cells alone (Fig. 
3 a). Such augmented responses were evident at 24 and 48 h  (only 48-h responses are 
shown).  Early  (4  h)  indurated  and  hemorrhagic lesions  (i.e.,  Arthus-like)  were not 
seen  in  recipients.  Immune  serum  alone  transferred  the  ability  to  elicit  skin  test 
reactions to the immunizing conjugate that were smaller than those seen with cells. 
PPD responses were less, though significantly (P <  0.001)  augmented by concomitant 
administration  of PEC  and serum, whereas  immune serum alone did  not have the 
ability to transfer reactivity to PPD skin testing (Fig.  3 b). 
Concomitant transfer of immune serum with immune cells altered the histological 
nature of the elicited  skin test  reactions.  Individually,  cells  and serum allowed  the 
elicitation  of respectively  strong and weak cutaneous basophil  responses.  Together, 
their  administration  resulted  in  suppression  of the  strong  basophil  infiltrate  that 
occurred with cells alone. The suppression of basophil infiltration was evident to skin 
testing with the immunizing conjugate Ox-KLH  (Fig.  3 a)  and PPD  (Fig.  3 b).  The 
reduced  basophil response is all the more surprising when viewed in the light of the 
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Fro.  3.  Immune  serum modulates  skin test  responses  in  recipients of immune  PEC.  Donors  were 
immunized  with  100 p,g  Ox-KLH  emulsified  with  CFA.  PEC  (1  donor: 1 recipient)  and  immune 
serum  (5  ml)  were  harvested  at  28  d  and  transferred  intravenously.  Data  were  pooled  from  six 
experiments.  Actively immunized and recipient animals were skin tested with  100 ~g Ox-KLH (Fig. 
3 a) and with 25/~g PPD  (Fig.  3 b). Statistically significant  differences represent comparisons  to the 
group that received cells alone, r-n, erythema; r~, basophils. 164  CUTANEOUS BASOPHIL HYPERSENSITIVITY SUPPRESSION 
TABLE  I 
Immune Serum Modulates Skin Test Responses to Various Doses of Antigen in Recipients of Immune PEC* 
Num- 
ber of  Skin test  Transferred  Macro-  ani-  dose 
mals  scopic ery- 
thema 
Recipient's skin test responses 
Microscopic cells per 5 1,000× fields ±  SE 
Eosino-  Neutro-  Mononu- 
Basophils  phils  phils  clear 
~tg  mm ± SE 
Cells(PEC)  6  30  9±  1  102±24  11±4  3±  1  74±  11 
18  100  14± 1  134± 12  7.4  1  12±5  54± 7 
6  300  16 .4 2.0  139 ±  30  13 ±  3  5 :l: 3  67 ±  20 
Serum  6  30  3±  I  17±8  7±  1  12±4  34±3 
6  100  9±4  29±6  19+6  4±2  37+7 
6  300  13± 1  24± 7  17±3  11 ±3  66± 7 
Cells +  serum  6  30  16 ±  2:~  49 ±  10~:  13 ±  4  10 ±  3  55 ±  17 
18  100  27 :t: 2:]:  54 :i: 10:[:  18 ±  4  30 ±  12~  79 :i: 4:~ 
6  300  32 ±  4:~  33±  10:[:  18±4  87 ±  20:[:  191 ±  11~: 
Nil  6  30  0  6-43  6-43  1+I  43-43 
6  100  2±1  2±1  6:t:3  8+6  34±3 
6  300  2:t:2  5±3  4-42  10-46  72±14 
* Donors were immunized with 100 #g Ox-KLH emulsified with CFA. PEC and immune serum harvested 
at 28 d were transferred intravenously at a dose of 1 donor to 1 recipient for the PEC and 5 ml for the 
serum.  1-2 h after transfer,  recipient animals were skin tested with 0.1  ml PBS containing 300/~g,  I00 
/~g, and 30 #g of Ox-KLH. 
:]: Statistically significant (P <  0.05) when compared with the group that received cells alone. 
augmented  macroscopic  reactions  that  were  present  when  skin  testing  with  the 
conjugate in particular  (Fig. 3 a). There were more neutrophils and mononuclear  cells 
in reactions of animals that  received cells plus serum than  in those that  received cells 
alone,  and  serum  alone  did  not  transfer  the  ability  to  elicit  skin  reactions  that  had 
high  neutrophil  counts  (Table  I).  Thus,  recipients  of cells plus  serum  had  strongly 
erythematous  and  indurated  reactions  that  had  a  predominant  mononuclear  cell 
infiltrate,  a  neutrophil  component,  and  diminished  basophils.  In  these  respects, 
reactions  in  recipients  of  cells  plus  serum  resembled  donor  responses  more  than 
reactions elicited in recipients of cells alone. 
The  finding  that  immune  serum  augmented  the  macroscopic  size  of reactions 
elicited  with  the  immunizing  conjugate  in  recipients  of immune  PEC  was  demon- 
strated at a  wide range of skin test doses, 30 #g,  100/~g, and 300/~g, as was suppression 
ofbasophil  infiltration (Table I). Thus, immune  serum modulation  of the macroscopic 
and  microscopic  aspects  of  cell-dependent  reactions  was  not  dependent  on  any 
particular skin test  dose. 
Concomitant  transfer  of immune  cells  (I:1  ratio)  and  fourfold  dilutions  of serum 
revealed that significnt macroscopic augmentation  and microscopic basophil suppres- 
sion  was  not  present  at  a  volume  of  1.25  ml  or  less.  Normal  serum  (5  ml)  did  not 
possess either activity (data  not shown). 
Macroscopic  Augmentation  Is  Antigen  Specific,  and  Microscopic  Suppression  of Basophil 
Infiltrates  Is  Nonspecific  (Fig.  4  and  Table  II).  To  ascertain  whether  the  ability  of E.  BRUCE  MITCHELL  AND  PHILIP  W.  ASKENASE  165 
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FIO. 4.  Specificity of immune serum that modulates skin test responses in recipients of immune 
PEC. Separate groups of donors were immunized with either Ox-KLH or Pic-HSA (t00/~g each) 
emulsified with CFA. PEC and immune serum were harvested at 28 d. Animals received immune 
cells  alone,  immune cells  plus  homologous immune serum, or  immune cells  plus  heterologous 
immune serum. Animals were skin tested with 100 #g Ox-KLH (Fig.  4a) or with 100 #g Pic-HSA 
(Fig. 4b). D, erythema; ~, basophils. 
TABLE  II 
Antigen-Affinity  Chromatography of Immune Serum That Modulates Skin  Test 
Responses in Recipients of Immune Cells* 
Immune components transferred 
Recipient's skin test responses 
Microscopic 
Macroscopic  basophils per 5 
erythema  1,000× fields 
±  SE 
mm ± SE 
Cells alone  12.3 ±  1.2  87.7  ±  4.5 
Cells +  serum  21.0 ±  1.5:~  53.3  ±  3.5:~ 
Cells +  Ox-KLH Sepharose  t3.7 ±  0.3  46.3  ±  11.3:~ 
column-passed serum 
* Donors were immunized with  100 #g Ox-KLH emulsified with CFA.  PEC 
and immune serum were harvested at  28  d.  Serum was passed through an 
Ox-KLH Sepharose affinity column. Recipient animals were skin tested with 
100 #g Ox-KLH. Each group consisted of three animals. 
:l: Statistically significant (P <  0.05)  when compared with cells alone group. 166  CUTANEOUS BASOPHIL HYPERSENSITIVITY SUPPRESSION 
immune  serum  to  macroscopically  augment  reaction  size  and  suppress  basophil 
infiltration was antigen specific, two groups of animals were immunized, each with a 
different hapten-protein conjugate in CFA. Ox-KLH and Pic-HSA were used as the 
immunizing  antigens.  Crossover  studies  were  done,  whereby  immune  cells  of one 
specificity were  transferred  either  alone  with  homologous  immune  serum  or  with 
heterologous immune serum. 
Fig.  4a  shows  that  macroscopic augmentation  of elicited  reactions  was  antigen 
specific.  Pic-HSA plus CFA  immune serum  did  not  significantly  enlarge  Ox-KLH 
responses elicited  after transfer of cells with Ox-KLH specificity, whereas Ox-KLH 
plus CFA immune serum did. In contrast, both homologous and heterologous immune 
CFA serum had the ability, when  administered with Ox-KLH cells, of suppressing 
basophil infiltration.  Fig. 4b shows that the heterologous Pic-HSA plus CFA serum 
that nonspecifically suppressed the ability of immune cells with Ox-KLH specificity 
to transfer the elicitability of basophil-rich delayed reactions could suppress basophil 
infiltration in a homologous system when administeed with cells of Pic-HSA specific- 
ity. Also,  Ox-KLH plus CFA-immune serum  transferred with  immune cells of Pic- 
HSA specificity suppressed the infiltration of basophils into Pic-HSA skin test lesions 
(Fig.  4 b). Macroscopically, homologous Pic-HSA-immune cells plus immune serum 
did augment reaction size, but this augmentation did not reach statistical significance. 
In contrast, Ox-KLH plus CFA serum had a  much reduced effect upon the macro- 
scopic size of Pic-HSA skin tests when given in combination with Pic-HSA-immune 
cells. 
These  data  suggest  that  the  ability  of immune  CFA  serum  to  macroscopically 
augment the elicited skin reaction size in recipients of immune cells is antigen specific, 
as it is only significant  in a  homologous system. However, immune CFA serum can 
suppress  the  infiltration  of basophils  into  such  reactions  in  an  antigen-nonspecific 
manner, as evidenced in two different immunization protocols. 
An  antigen  affinity column  was  used  to  further  investigate  the  dual  activity of 
immune CFA serum.  16  ml of 28-d Ox-KLH plus CFA-immune serum was passed 
through  an Ox-KLH-Sepharose column.  All  anti-oxazolone and  anti-KLH hemag- 
glutinating antibody was removed (data not shown). The passed serum was concen- 
trated  and  administered  in  5-ml equivalent  volumes. Table II shows  that  immune 
serum that macroscopically augmented reactions elicited in immmune cell recipients 
lost this activity after passage through  an antigen  affinity column.  In contrast,  the 
ability of the immune serum to suppress basophil infiltration into such reactions was 
not altered by passage through an antigen affinity column. This further suggests that 
these two serum activities are separable and distinct, as one (macroscopic augmenta- 
tion) binds to an antigen column and one (basophil suppression) does not. 
Fractionation of Immune Serum That Modulates Skin  Test Responses in Recipients of Immune 
Cells (Tables III and IV).  An  18 g% Na2SO4 glolubin fraction of immune serum (Ox- 
KLH  plus  CFA)  was  applied  to  a  DEAE  column  and  eluted  as  three  peaks with 
stepwise  changes  in  buffer.  Hemagglutination  titers,  PCA  titers,  and  macroscopic 
augmenting and  basophil-suppressing activity were assessed  for each  fraction.  The 
initial globulin fraction retained the ability to both macroscopically augment reactions 
and suppress the infiltration  of basophils when  administered with immune PEC  to 
recipient animals that were skin tested with Ox-KLH. The IgG2-containing fraction 
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TABLE III 
DEAE Ion Exchange Chromatography of  Immune Serum That Modulates Skin 
Test Responses in Recipients of Immune Cells* 
Reclpient's skin test responses 
Immune components  Microscopic basophils 
transferred  Macroscopic 
erythema  per 5 1,000× fields 4- 
SE 
ram ± SE 
Cells alone  13.0 4- 0.9  146.8 4- 12.0 
Cells + serum  27.3 4- 1.3:1:  47.0 4- 16.5~ 
Cells +  IgG2 fraction  18.2 4- 1.3~  137.2 4- 13.2 
* Donors were immunized with  100 pg Ox-KLH emulsified with CFA. PEC 
and  immune serum were harvested at  28 d.  Serum was  fractionated on a 
DEAE cellulose column. Data is shown only for the IgG¢ fraction. Recipient 
animals were skin  tested with  100/~g Ox-KLH. Results were pooled from 
two experiments with six animals in each group. 
:[: Statistically significant when compared with the cells alone group. 
TABLE IV 
Sephadex G200 Gel Filtration Chromatography of Immune Serum That 
Modulates Skin Test Responses in Recipients of Immune Cells* 
Immune components transferred 
Recipient's skin test responses 
Microscopic 
Macroscopic  basophils per 
erythema  5 1,000X 
fields 4- SE 
mm ± SE 
Cells alone  11.2 ±  0.5  112.8 4-  6.3 
Cells +  excluded fraction  10.0 4- 1.2  112.0 ±  24.6 
Cells +  IgG-sized fraction  18.7 ±  1.8~  127.0 +  10.7 
Ceils +  albumin-sized fraction  19.0 4- 2.52:~  51.0 ±  7.1~ 
* Donors were immunized with  100/~g Ox-KLH emulsified with CFA. PEC 
and  immune serum were harvested at  28 d.  Serum was fractionated on a 
Sephadex G-200  column.  Recipient animals were skin  tested with  100 #g 
Ox-KLH. Each group consisted of three animals. 
:~ Statistically significant when compared with the cells alone group. 
similar circumstances,  but this fraction did not have the basophil-suppressing  activity 
(Table  III).  Neither  the  IgG1  serum  fraction  nor  the  third  fraction  from  the  DEAE 
column  had  macroscopic  augmenting  activity  or  detectable  basophil-suppressing 
activity;  this  latter  activity  might  have  been  lost  during  fractionation.  The  IgG2 
fraction  had  most  of the  hemagglutinating  anti-oxazolone  and  anti-KLH  antibody 
activity of whole serum, and the IgG1 fraction had virtually all of the PCA activity of 
both specificities (data not shown). 
A  Sephadex  G-200 column  (90 X  5  cm)  was used  to assess the size of serum  factors 
that  had  the  ability  to  suppress  basophil  infiltrates.  19  ml  of immune  serum  was 
applied  to  the column,  and  three  major  protein  peaks  were collected.  Concentrated 
pools of fractions representing  these three peaks were transferred  concomitantly  with 
immune  cells.  Table  IV  shows  that  neither  the  excluded  fraction  nor  the  IgG-sized 
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TABLE  V 
Comparison of 7-d vs. 28-d Immune Serum Activity in Modulation of Skin 
Test Responses in Recipients of 7-d Immune Cells * 
Recipient's skin test responses 
Immune components  Microscopic baso- 
transferred  Macroscopic  phils per 5 1,000× 
erythema  fields 4" SE 
rnm + SE 
Cells (7 d)  13 ± 2.3  134 + 33.2 
Cells (7 d) + serum (7 d)  11 ± 3.0  156 ± 51.6 
Cells (7 d) + serum (28 d)  17 ±  1.2  115 ±  12.5 
* Donors were immunized  with  100/~g Ox-KLH emulsified with CFA. PEC 
and immune  serum were harvested  at either 7 d or 28 d. Early (7 d) cells 
were  administered with  either early  (7  d)  serum  or  late  (28  d)  serum. 
Recipient animals were skin tested with 100/lg Ox-KLH. There were three 
animals in each group. Later (28 d) serum had the property of significantly 
suppressing basophil infiltration when given with late (28 d) cells. 
albumin-sized  fraction  did  have  this  activity,  thus  suggesting  that  the  responsible 
serum factor has an ~ 70,000 mol wt. Both the IgG-sized and albumin-sized fractions 
had  macroscopic  augmenting  activity, suggesting  that  some overlap  of these  peaks 
occurred.  This  might  be because  the  column  was  overloaded  (19  ml  of serum  was 
applied,  and  fraction  pools were  transferred  to  three  recipients)  in  anticipation of 
losses in basophil suppression activity. 
Modulation of Skin Reactions  Is a Property of Late (28-d) Serum plus Cells and Not of Either 
Early  (7-d)  Serum  or  Cells  (Table  V).  Animals immunized  to express DH  responses 
will express basophil-containing responses  7 d  after immunization  (7,  10,  15). There- 
fore, the effects of concomitant  transfer of 7-d immune  cells plus either  7-d or 28-d 
immune serum were investigated. Table V  shows that neither 7-d nor 28-d serum had 
the ability to suppress the basophil infiltration of reactions elicited after transfer of 7- 
d  cells. Some macroscopic augmentation did occur with 28-d serum, though this was 
not  statistically significant. These  results suggest  that  immune  cells generated  early 
(7 d)  after immunization  for DH  responses are different  from  later  (28-d)  occurring 
immune cells because they are more difficult to macroscopically augment and because 
they are not susceptible to basophil suppression by late (28-d) immune serum known 
to have such properties. By inference, the data suggest that early cells are more likely 
to express the capacity to recruit hasophils to delayed reactions as is the case. 
Discussion 
Delayed cutaneous reactions that are elicited by specific antigen in a sensitized host 
are  complex  processes  consisting  of  several  components.  When  guinea  pigs  are 
immunized  with  a  protein  antigen  emulsified  with  complete  Freund's  adjuvant, 
classical tuberculin-type DH  reactions  are  elicited by  PPD  or  by  the  immunizing 
protein antigen.  Macroscopically, DH  reactions have  a  characteristic delayed onset 
(6-8  h  after  testing),  a  broad  peak  over  24-48  h,  and  are  characterized  by  strong 
erythema  and  induration.  Microscopically,  DH  reactions  are  rich  in  monocyte/ 
macrophages  that  are  recruited  from  the  bone  marrow  via  the  blood.  Basophils 
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comprise 25-60% of the infiltrate in delayed, weakly erythematous, and nonindurated 
CBH responses that are elicited in guinea pigs immunized with proteins administered 
without mycobacterial adjuvant (4,  7,  15). 
The  T  cell  dependence  of DH  responses  is  apparent  from  the  hapten-carrier 
specificity of reactions  elicited  in  actively sensitized  animals  and  by the  fact  that 
elicitability of delayed reactions of similar fine specifity requirements is transferable 
from these animals to normal recipients by live sensitized T  cells and not by soluble 
serum  components  (7,  16).  However, careful  examination  of reactions  elicited  in 
recipients of immune T cells reveals that these responses differ significantly from those 
of the donors. In particular, recipient responses are weaker in intensity of erythema 
and  induration, and microscopically they contain significant infiltrates of basophils 
(7). Therefore, recipient reactions resemble CBH responses rather than DH responses 
that  are  elicited  in  the  donors.  Thus,  the  landmark  cell  transfer  experiments  of 
Landsteiner and Chase in  1942 were in fact probably T  cell transfers of CBH from 
donors with DH. These T  cell transfers of CBH from donors with DH are not due to 
major histocompatibility complex restrictions or an allogeneic effect, as they occur 
between strain  13 inbred guinea pigs (7) as well as between outbred Hartley guinea 
pigs. 
The current  study has compared reactions elicited in  recipients of cells alone to 
those  of animals  receiving  both  immune  cells  and  immune  serum.  Our  findings 
indicate that  components of immune serum act in concert with immune T  cells to 
produce elicitation of reactions in  recipients that  more fully resemble those of the 
donors then do reactions in recipients of cells alone. At least two serum components 
are responsible for this modulation of T  cell-dependent delayed reactions. One is an 
antigen-specific IgG2 antibody that  leads  to macroscopic augmentation  of the cell- 
mediated response. The other is a nonantigen-specific albumin-sized serum component 
that leads to suppression of the T  cell-dependent microscopic basophil infiltrates. 
The  macroscopic augmentation  was  antigen  specific, as  it  was  not  present  with 
serum from donors immunized with another antigen in CFA and was removed by an 
antigen affinity column. Asherson and Loewi (17) also reported a synergistic action of 
immune cells and immune serum in the passive transfer of delayed hypersensitivity. 
However,  partial  augmentation  of cell  transfer  could  be  demonstrated  after  the 
induction or an irrelevant antigen-antibody reaction at the skin test site (18, 19). The 
current experiments support the concept that an antigen-antibody reaction is respon- 
sible  for macroscopic augmentation  by demonstrating that  IgG~ antibody has  this 
property.  This  antibody  isotype  has  the  ability  to  fix  complement,  and  such  a 
mechanism or antigen retention at the skin test site might participate in the augmented 
response. However, the exact mechanism of augmentation by antibody is not clear, as 
there is differing evidence available for different antigens and immunization protocols 
(18,  20,  21).  Only  a  small  but  significant  increase  in  macroscopic  reactions  was 
demonstrable when  skin  testing with  PPD,  whereas  a  more marked augmentation 
was  present when testing with  the hapten-protein conjugate.  A  poor IgG antibody 
response to PPD at 4 wk after immunization might explain this difference. 
Immune serum  from animals  immunized with  CFA was  found to have the very 
important property of suppressing the basophil-rich histology present after transfer of 
immune ceils  alone.  Interestingly,  this  property was  not  found  in  the  IgG2  serum 
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The activity of suppressing basophils was not antigen specific, as it could be elicited 
when immune ceils were transferred in combination with serum from donors immu- 
nized with another antigen in CFA, and basophil-suppressing activity was still present 
after specific immune serum  was  passed  through  an  antigen  affinity column.  Gel 
filtration chromatography revealed that  the basophil-suppressing activity resided in 
the albumin-sized fraction, though possibly it was caused by an even smaller molecule 
that was albumin bound. It is tempting to speculate that the activity was caused by 
a  cell product and to compare it with analogous regulatory factors in CFA-induced 
serum that selectively suppress IgE antibody responses (22). In the mouse, Kishimoto 
(23) has demonstrated that such a factor is a T  cell product with a 55,000-60,000 mol 
wt. Thus far, our attempts at producing the basophil-suppressing factor in vitro have 
not been successful (Mitchell and Askenase, unpublished observations). 
Basophil-rich delayed-onset reactions are elicited at early intervals after immuni- 
zation  with  soluble  protein  antigens  emulsified with  CFA,  but,  at  later  intervals, 
basophil-poor and mononuclear cell-rich DH reactions are elicited (4, 15). Comparison 
of reactions elicited after transfer only of early cells (7-d postimmunization) with those 
elicited  after  transfer  of early  cells  plus  early  serum  revealed  that  macroscopic 
augmentation and basophil suppression did not occur. Later serum (28 d), which was 
known  to possess basophil-suppressing  activity when administered with  late  (28 d) 
cells, failed to suppress cell-dependent basophil infiltrates when transferred with early 
(7 d) ceils. These results suggest a distinct difference between early and late immune 
cells  after  immunization  with  CFA.  Early  ceils  are  resistant  to  CBH-suppressive 
activity of late serum,  and  it  is  at  this  stage  that  early cells are  most  effective in 
recruiting basophils. It has been shown (24) that cells from animals immunized with 
CFA in which hospital infiltrates are suppressed are potent producers of lymphokines 
that  are  chemotactic for basophils.  The serum  activity we  described  might  either 
prevent the production of, or render inoperative, such chemotactic stimuli. 
In conclusion, our results suggest that elicitibility of DH reactions is not achieved 
by transfer ofT cells alone, although these responses are T cell dependent. Additional 
antigen-specific and  antigen-nonspecific  factors  in  immune  serum  are  required  to 
elicit delayed responses in recipients that more faithfully reproduce those elicited in 
the donors. The biological utility of this phenomenon is not clear. However, delayed 
basophil  infiltrates  are  required  for  immune  rejection of some  large  multicellular 
parasites,  2 whereas  monocyte/macrophage-rich responses  are  more  appropriate  to 
immune resistance to facultative intracellular microorganisms, such as mycobacteria 
(1, 25, 26). Therefore, the ability of specific and nonspecific factors in immune serum 
to modulate the basophil vs. monocyte/macrophage component of T  cell-dependent 
tissue responses might have important biological consequences. 
Summary 
Guinea pigs immunized with protein antigens emulsified with complete Freund's 
adjuvant  (CFA)  and  skin  tested  at  3-4  wk  have classical  tuberculin-type delayed 
hypersensitivity (DH) reactions with few basophils present. However, recipients of T 
cells from these animals have delayed responses containing large basophil infiltrates 
2 Brown,  S. J.,  S. J.  Galli, G.  Gliech,  and  P.  W.  Askenase.  1982.  Ablation of immunity  to Ambyloma 
americanium  by  anti-basophil  serum:  cooperation  between  basophils  and  eosinophils  in  expression  of 
immunity to ectoparasites (ticks) in guinea pigs.,]. ImmunoL In press. E.  BRUCE  MITCHELL AND  PHILIP W.  ASKENASE  171 
and thus resemble basophil-rich cutaneous basophil hypersensitivity (CBH) responses 
that  are  elicited  in  animals  immunized  without  CFA.  This  suggests  that  animals 
immunized  with  CFA have  T  cells  with  basophil-recruiting  capacity  but  that  this 
activity is suppressed. 
Using a  transfer  system,  we  found  that  immune  serum  from  donors  immunized 
with CFA had the ability to suppress the basophil-recruiting capacity of immune T 
cells. When immune serum and peritoneal exudate cells from guinea pigs immunized 
with  CFA were co-transferred  intravenously to normal  recipients,  the cell-mediated 
transfer of basophil-rich  responses was suppressed.  The responsible serum factor was 
antigen  nonspecific,  had an  -70,000  mol wt,  and acted preferentially  on cells  from 
donors that express basophil-poor DH responses. 
Thus, tuberculin-type delayed hypersensitivity and CBH might be mediated  by a 
common T  cell, but the resulting basophil component of the delayed response depends 
on  the  modulation  of T  cell  recruitment  of basophils  by  factors  in  CFA-immune 
serum. 
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